Paper19243003
A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.
Alabraba E and 6 others. Liver Transpl, 2009. Cited by 218 papers, by iCite.
Cite this record
ConductScience Library. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Papers, record 19243003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19243003
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.
- PubMed
Topics26
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cholangitis, Sclerosing | Major topic |
| Liver Transplantation | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Cadaver | |
| Colectomy | |
| Female | |
| Follow-Up Studies | |
| Graft Rejection | |
| Graft Survival | |
| HLA Antigens | |
| Humans | |
| Immunosuppressive Agents | |
| Male | |
| Middle Aged | |
| Patient Selection | |
| Recurrence | |
| Retrospective Studies | |
| Risk Factors | |
| Sex Characteristics | |
| Survival Analysis | |
| Survivors | |
| Tissue Donors | |
| Transplantation, Homologous | |
| Young Adult |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 19790228 | The urgent need for evaluating recurrent primary sclerosing cholangitis in living donor liver transplantation. | https://conductscience.org/library/papers/19790228 |
Source PubMed
Cited by97
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 218 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41997362 | Microbial Monotherapy With Leuconostoc sp LB-P8 Improves Inflammation and Fibrosis in Mouse Primary Sclerosing Cholangitis by Inhibiting Transforming Growth Factor β1/SMAD Signaling. | Cell Mol Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/41997362 | PubMed |
| 41857231 | Distinct phenotype of primary sclerosing cholangitis-associated inflammatory bowel disease. | J Gastroenterol | 2026 | https://conductscience.org/library/papers/41857231 | PubMed |
| 41825099 | Evaluation and management of primary sclerosing cholangitis patients awaiting liver transplantation. | JHEP Rep | 2026 | https://conductscience.org/library/papers/41825099 | PubMed |
| 41737226 | Mortality trends and demographic-geographic disparities of autoimmune liver diseases among U.S. adults aged ≥45 years, 1999-2023. | Front Immunol | 2026 | https://conductscience.org/library/papers/41737226 | PubMed |
| 41590547 | Reply to Mammadov et al. Comment on "Catanzaro et al. Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center Data. J. Pers. Med. 2024, 14, 222". | J Pers Med | 2026 | https://conductscience.org/library/papers/41590547 | PubMed |
| 41406236 | RIPK1 inhibition reduces biliary injury and fibrosis in primary sclerosing cholangitis. | Sci Adv | 2025 | https://conductscience.org/library/papers/41406236 | PubMed |
| 41227212 | Gut-Liver Axis, Microbiota, Bile Acids, and Immune Response in Pathogenesis of Primary Sclerosing Cholangitis: An Overview. | J Clin Med | 2025 | https://conductscience.org/library/papers/41227212 | PubMed |
| 41122155 | Long-term results of celiac disease patients who underwent liver transplantation. | Hepatol Forum | 2025 | https://conductscience.org/library/papers/41122155 | PubMed |
| 40124424 | All you need to know about the overlap between primary sclerosing cholangitis and inflammatory bowel disease. | Ann Gastroenterol | 2025 | https://conductscience.org/library/papers/40124424 | PubMed |
| 40082445 | Primary sclerosing cholangitis. | Nat Rev Dis Primers | 2025 | https://conductscience.org/library/papers/40082445 | PubMed |
| 39888688 | Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver Transplantation. | Am J Gastroenterol | 2025 | https://conductscience.org/library/papers/39888688 | PubMed |
| 39774274 | Management of primary sclerosing cholangitis: Current state-of-the-art. | Hepatol Commun | 2024 | https://conductscience.org/library/papers/39774274 | PubMed |
| 39679639 | Outcome of Liver Retransplantation in Patients With Primary Sclerosing Cholangitis. | Liver Int | 2025 | https://conductscience.org/library/papers/39679639 | PubMed |
| 39673746 | Open Label Vancomycin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Improved Colonic Disease Activity and Associations With Changes in Host-Microbiome-Metabolomic Signatures. | J Crohns Colitis | 2025 | https://conductscience.org/library/papers/39673746 | PubMed |
| 39476285 | Impact of graft type on outcomes following liver transplantation for primary sclerosing cholangitis. | Hepatol Int | 2025 | https://conductscience.org/library/papers/39476285 | PubMed |
| 39258375 | Long-term Outcomes Following Colectomy and Liver Transplantation for Inflammatory Bowel Disease With Primary Sclerosing Cholangitis. | Ann Surg | 2026 | https://conductscience.org/library/papers/39258375 | PubMed |
| 39199562 | The Impact of Biliary Injury on the Recurrence of Biliary Cancer and Benign Disease after Liver Transplantation: Risk Factors and Mechanisms. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39199562 | PubMed |
| 39167239 | Ileal pouch-anal anastomosis and end ileostomy result in equivalent graft survival following liver transplantation for inflammatory bowel disease-primary sclerosing cholangitis. | Tech Coloproctol | 2024 | https://conductscience.org/library/papers/39167239 | PubMed |
| 38975605 | Recurrence of Primary Disease After Adult Liver Transplant - Risk Factors, Early Diagnosis, Management, and Prevention. | J Clin Exp Hepatol | 2024 | https://conductscience.org/library/papers/38975605 | PubMed |
| 38540965 | Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center Data. | J Pers Med | 2024 | https://conductscience.org/library/papers/38540965 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19243003
GET https://conductscience.org/api/papers/v1/19243003/cited_by?page=2